
Chinook Therapeutics (KDNY)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Chinook Therapeutics (KDNY) Stock
Start investing in Chinook Therapeutics (KDNY)
About Chinook Therapeutics (KDNY)
Market cap | $2.9B |
Today's volume | — |
Revenue (TTM) | — |
Avg. daily volume | 1.91M |
EBITDA (TTM) | — |
Open | — |
Price / earnings ratio | -11.49x |
Today's range | — |
Debt / equity | — |
52 week range | $18.34 - $40.51 |
5 year debt / equity | 15.27x |
Beta (LTM) | 1.05x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | — |
Ex-dividend date | — |
Next earnings | Nov 5, 2020 |
Dividend payable date | — |
Chinook Therapeutics Stock Rating
Chinook Therapeutics Stock News
View all



Frequently Asked Questions (FAQ)
How to buy KDNY stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in KDNY stock
Navigate to the Explore page. Then, type KDNY into the search bar. When you see KDNY stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased KDNY stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Chinook Therapeutics Stock Earnings
The value each KDNY share was expected to gain vs. the value that each KDNY share actually gained.
Chinook Therapeutics (KDNY) reported earnings per share (EPS) of $0, — estimates of $0 by —. In the same quarter last year, Chinook Therapeutics's earnings per share (EPS) was $0. Chinook Therapeutics is expected to release next earnings on 11/05/2020, with an earnings per share (EPS) estimate of $0.